Related references
Note: Only part of the references are listed.Disruption of estrogen receptor signaling enhances intestinal neoplasia in ApcMin/+ mice
Alicia G. Cleveland et al.
CARCINOGENESIS (2009)
A Cohort Study of Cyclin D1 Expression and Prognosis in 602 Colon Cancer Cases
Shuji Ogino et al.
CLINICAL CANCER RESEARCH (2009)
Short term outcome after emergency and elective surgery for colon cancer
O. H. Sjo et al.
COLORECTAL DISEASE (2009)
Oral contraceptives and neoplasms other than breast and female genital tract
Carlo La Vecchia et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2009)
Gender-related survival differences associated with EGFR Polymorphisms in metastatic colon cancer
Oliver A. Press et al.
CANCER RESEARCH (2008)
Cyclin D1 is frequently overexpressed in microsatellite unstable colorectal cancer, independent of CpG island methylator phenotype
K. Nosho et al.
HISTOPATHOLOGY (2008)
Diet and body constitution in relation to subgroups of breast cancer defined by tumour grade, proliferation and key cell cycle regulators
Signe Borgquist et al.
BREAST CANCER RESEARCH (2007)
Profiling markers of prognosis in colorectal cancer
MS Lyall et al.
CLINICAL CANCER RESEARCH (2006)
ERβ isoform expression in colorectal carcinoma:: an in vivo and in vitro study of clinicopathological and molecular correlates
NACS Wong et al.
JOURNAL OF PATHOLOGY (2005)
Immunoprofiles of 11 biomarkers using tissue microarrays identify prognostic subgroups in colorectal cancer
T Knösel et al.
NEOPLASIA (2005)
Expression and gene amplification of primary (A, B1, D1, D3, and E) and secondary (C and H) cyclins in colon adenocarcinomas and correlation with patient outcome
J Bondi et al.
JOURNAL OF CLINICAL PATHOLOGY (2005)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients
AA Bahnassy et al.
BMC GASTROENTEROLOGY (2004)
Cyclin DI overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients
M Stendahl et al.
BRITISH JOURNAL OF CANCER (2004)
Expression of non-membranous beta-catenin and gamma-catenin, c-Myc and cyclin D1 in relation to patient outcome in human colon adenocarcinomas
J Bondi et al.
APMIS (2004)
Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial
JE Rossouw et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Analysis of key cell-cycle checkpoint proteins in colorectal tumours
JA McKay et al.
JOURNAL OF PATHOLOGY (2002)
Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer
H Elsaleh et al.
LANCET (2000)
Protein expression of p53, p21 (WAF1/CIP1), bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas
IK Bukholm et al.
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY (2000)
Share Paper
